Strategies for developing novel therapeutics for sensorineural hearing loss
Sensorineural hearing loss (SNHL) is a common disability in the world; however, at present, options for the pharmacological treatment of SNHL are very limited. Previous studies involving human temporal bone analyses have revealed that the degeneration of the cochlea is a common mechanism of SNHL. A...
Saved in:
Main Author: | Takayuki eNakagawa (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss
by: Takayuki eOkano
Published: (2014) -
Future Pharmacotherapy for Sensorineural Hearing Loss by Protection and Regeneration of Auditory Hair Cells
by: Mami Matsunaga, et al.
Published: (2023) -
Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
Published: (2021) -
Development of Chinese herbal medicine for sensorineural hearing loss
by: Yunhao Wu, et al.
Published: (2024) -
Sensorineural hearing loss in Kawasaki disease
by: Varun Aggarwal, et al.
Published: (2016)